Jean-Louis Mège Selected Research

Jean-Louis Mège Research Topics

Disease

6	Infections 01/2022 - 11/2003
2	COVID-19 01/2023 - 12/2022
2	Whipple Disease (Whipple's Disease) 01/2021 - 11/2018
2	Endocarditis 11/2019 - 01/2018
2	Q Fever (Fever, Q) 11/2019 - 01/2018
2	Thrombosis (Thrombus) 05/2019 - 01/2018
2	Hypersensitivity (Allergy) 01/2019 - 01/2017
2	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 01/2017
2	Sepsis (Septicemia) 01/2018 - 04/2002
2	Bacterial Infections (Bacterial Infection) 01/2016 - 01/2011
1	Antisynthetase syndrome 01/2023
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2023
1	Pneumonia (Pneumonitis) 12/2022
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Pulmonary Alveolar Proteinosis 02/2021
1	Brain Abscess (Abscess, Brain) 02/2021
1	Lipoid Proteinosis of Urbach and Wiethe (Lipoidproteinosis) 02/2021
1	Leukopenia 01/2021
1	Candidemia 01/2021
1	Arthralgia (Joint Pain) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Lymphoma (Lymphomas) 05/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Tuberculosis (Tuberculoses) 05/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2019
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2019
1	Immediate Hypersensitivity 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2019
1	Meningitis 01/2018
1	Hepatitis 01/2018
1	Cholecystitis 01/2018
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2018
1	Allergic Bronchopulmonary Aspergillosis 01/2017
1	Brucellosis (Malta Fever) 01/2016
1	Coinfection 01/2014
1	Granuloma 01/2014
1	Septic Shock (Toxic Shock Syndrome) 04/2002
1	Hemorrhagic Shock 04/2002

Drug/Important Bio-Agent (IBA)

4	Immunoglobulin G (IgG)IBA 12/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
3	AllergensIBA 01/2019 - 01/2018
2	AutoantibodiesIBA 01/2023 - 02/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2011
2	Anticardiolipin AntibodiesIBA 11/2019 - 01/2018
2	AntibodiesIBA 05/2019 - 01/2018
2	Tryptases (Tryptase)IBA 01/2019 - 01/2018
2	Immunoglobulin E (IgE)IBA 01/2018 - 01/2017
1	Antiphospholipid AntibodiesIBA 01/2023
1	HLA-DR Antigens (HLA-DR)IBA 12/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2021
1	LactamsIBA 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020
1	CollagenIBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2019
1	Ethanolamine (Colamine)IBA 05/2019
1	AnticoagulantsIBA 05/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	HLA-G Antigens (HLA G)IBA 11/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2018
1	Natriuretic PeptidesIBA 01/2018
1	landiololIBA 01/2018
1	PrecipitinsIBA 01/2017
1	Arachidonic Acid (Vitamin F)IBA 01/2016
1	LeukotrienesIBA 01/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014
1	Interferon Type IIBA 01/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2011
1	Interferon-gamma (Interferon, gamma)IBA 11/2003
1	SelectinsIBA 04/2002
1	Cell Adhesion MoleculesIBA 04/2002
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2002

Therapy/Procedure

4	Therapeutics 12/2022 - 11/2003
2	Immunotherapy 01/2022 - 01/2021
1	Artificial Respiration (Mechanical Ventilation) 12/2022
1	Oral Administration 01/2020
1	Microspheres (Microsphere) 01/2014
1	Hip Prosthesis 11/2003